Supriya Lifescience Limited (SUPRIYA) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.051x

Based on the latest financial reports, Supriya Lifescience Limited (SUPRIYA) has a cash flow conversion efficiency ratio of 0.051x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs555.65 Million ≈ $6.01 Million USD) by net assets (Rs10.82 Billion ≈ $116.99 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See SUPRIYA equity financing ratio to measure how much of total assets are equity-financed.

Supriya Lifescience Limited - Cash Flow Conversion Efficiency Trend (2018–2025)

This chart illustrates how Supriya Lifescience Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check SUPRIYA cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Supriya Lifescience Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Supriya Lifescience Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Kingsgate Consolidated Ltd AU:KCN	0.153x
Shanghai Bolex Food Technology Co. Ltd. SHG:603170	N/A
Changchun Zhiyuan New Energy Equipment Co. Ltd SHE:300985	0.128x
Employers Holdings Inc NYSE:EIG	0.003x
BAE Systems plc LSE:BA	0.265x
HOB Biotech Group Corp Ltd SHG:688656	0.018x
Strait Innovation Internet Co Ltd SHE:300300	-0.098x
Renta 4 Banco S.A MC:R4	0.031x

Annual Cash Flow Conversion Efficiency for Supriya Lifescience Limited (2018–2025)

The table below shows the annual cash flow conversion efficiency of Supriya Lifescience Limited from 2018 to 2025. For the full company profile with market capitalisation and key ratios, see SUPRIYA stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs9.97 Billion ≈ $107.80 Million	Rs1.73 Billion ≈ $18.66 Million	0.173x	+24.58%
2024-03-31	Rs8.15 Billion ≈ $88.18 Million	Rs1.13 Billion ≈ $12.25 Million	0.139x	+46.86%
2023-03-31	Rs6.99 Billion ≈ $75.64 Million	Rs661.87 Million ≈ $7.16 Million	0.095x	+19.38%
2022-03-31	Rs6.16 Billion ≈ $66.58 Million	Rs488.01 Million ≈ $5.28 Million	0.079x	-73.33%
2021-03-31	Rs2.69 Billion ≈ $29.08 Million	Rs799.30 Million ≈ $8.64 Million	0.297x	-61.80%
2020-03-31	Rs1.49 Billion ≈ $16.13 Million	Rs1.16 Billion ≈ $12.55 Million	0.778x	+49.91%
2019-03-31	Rs937.91 Million ≈ $10.14 Million	Rs486.72 Million ≈ $5.26 Million	0.519x	+62.52%
2018-03-31	Rs546.57 Million ≈ $5.91 Million	Rs174.52 Million ≈ $1.89 Million	0.319x	--

About Supriya Lifescience Limited

NSE:SUPRIYA India Biotechnology

Market Cap

$765.64 Million

Rs70.80 Billion INR

Market Cap Rank

#9971 Global

#505 in India

Share Price

Rs879.65

Change (1 day)

+1.46%

52-Week Range

Rs553.35 - Rs1052.50

All Time High

Rs1052.50